ストックスクリーナーアプリを入手
414.86
1.49%
-6.29
プレマーケット:
416.70
1.84
+0.44%
Vertex Pharmaceuticals Inc (VRTX) 最新ニュース
Optas LLC Lowers Stock Position in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Vontobel Holding Ltd. Decreases Stake in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Weiss Ratings Reiterates "Hold (C+)" Rating for Vertex Pharmaceuticals (NASDAQ:VRTX) - MarketBeat
Vertex Pharmaceuticals Experiences Evaluation Revision Amid Mixed Market Indicators - Markets Mojo
Recovering from injury, Boston Celtics star Jayson Tatum laces up for Vertex campaign - Medical Marketing and Media
Is Vertex Stock Poised for Growth After Positive CRISPR Therapy Trial Results in 2025? - Yahoo Finance
Odyssey Therapeutics Appoints Pharmaceutical Leader Nia Tatsis, Ph.D., to Its Board of Directors - Business Wire
Prime Capital Investment Advisors LLC Cuts Stake in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Vertex Pharmaceuticals (NASDAQ:VRTX) Given New $530.00 Price Target at JPMorgan Chase & Co. - MarketBeat
Healthcare Stocks Are Rising: Here Are 2 With Even More Upside Ahead - The Motley Fool
Vertex’s quest for a breakthrough in Type 1 diabetes - Pharma Voice
Investors Heavily Search Vertex Pharmaceuticals Incorporated (VRTX): Here is What You Need to Know - Yahoo Finance
RBC Raises Price Target on Vertex Pharmaceuticals to $423 From $405, Keeps Sector Perform Rating - MarketScreener
Dohj LLC Purchases Shares of 857 Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
The Smartest Growth Stock to Buy With $500 Right Now - Yahoo Finance
The 5 Most Powerful Women in Biopharma - BioSpace
Vertex Pharmaceuticals (VRTX): Buy, Sell, or Hold Post Q2 Earnings? - Yahoo Finance
Vertex Pharmaceuticals Incorporated $VRTX Stake Lifted by KLP Kapitalforvaltning AS - MarketBeat
Shell Asset Management Co. Raises Holdings in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
SteelPeak Wealth LLC Makes New $10.06 Million Investment in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Simplicity Wealth LLC Purchases 1,736 Shares of Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Is Vertex Pharmaceuticals a Smart Investment After Recent FDA Approval for Sickle Cell Therapy? - Sahm
Vertex to Announce Third Quarter 2025 Financial Results on November 3rd - Business Wire
Former Vertex COO named chief executive at Dravet-focused biotech - The Business Journals
What Makes Vertex Pharmaceuticals (VRTX) an Investment Bet? - Yahoo
Vertex Pharmaceuticals: Strong Growth Potential with Promising Product Launches and Robust Pipeline - TipRanks
Cullinan Associates Inc. Sells 1,100 Shares of Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Will Vertex Pharmaceuticals Incorporated price bounce be sustainableJuly 2025 Momentum & AI Enhanced Execution Alerts - newser.com
Published on: 2025-10-06 04:49:48 - newser.com
DAVENPORT & Co LLC Grows Stock Holdings in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Global Assets Advisory LLC Sells 1,124 Shares of Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
QRG Capital Management Inc. Raises Position in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Why Vertex Pharmaceuticals Incorporated (VX1) stock remains top ratedQuarterly Portfolio Summary & Weekly High Return Stock Opportunities - newser.com
Is Vertex Pharmaceuticals Incorporated reversing from oversold territoryWeekly Trade Report & Precise Swing Trade Entry Alerts - newser.com
Will Vertex Pharmaceuticals Incorporated (VX1) stock outperform value peersMarket Volume Report & Free High Accuracy Swing Entry Alerts - newser.com
Vertex Pharmaceuticals (VRTX) Highlights Pipeline Progress at BofA Global Healthcare Conference - MSN
Chart based exit strategy for Vertex Pharmaceuticals IncorporatedMarket Rally & Daily Stock Trend Watchlist - newser.com
News impact scoring models applied to Vertex Pharmaceuticals IncorporatedQuarterly Investment Review & Weekly Watchlist of Top Performers - newser.com
Boston Common Asset Management LLC Has $20.51 Million Stock Position in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Can Vertex Pharmaceuticals Incorporated stock resist sector downturnsTrade Entry Summary & Breakout Confirmation Trade Signals - newser.com
Strid Group LLC Takes Position in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Why Vertex Pharmaceuticals Incorporated (VX1) stock could outperform next year2025 Technical Overview & Reliable Breakout Forecasts - newser.com
Ascent Group LLC Sells 790 Shares of Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
AMF Tjanstepension AB Increases Stock Position in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
J. Safra Sarasin Holding AG Has $1.34 Million Stake in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
NHS England to Offer Alyftrek for Cystic Fibrosis - respiratory-therapy.com
Insider Sell: Jonathan Biller Sells Shares of Vertex Pharmaceuticals Inc (VRTX) - GuruFocus
Vertex Pharmaceuticals (VRTX) Stock Dips While Market Gains: Key Facts - Yahoo Finance
ServiceNow, Vertex Pharmaceuticals And More: CNBC's 'Final Trades' - Benzinga
With Emma Walmsley exiting GSK, who will be pharma’s top women CEOs? - Pharma Voice
Vertex Pharmaceuticals (VRTX): Assessing Valuation as Shares Hold Steady and Long-Term Prospects Remain Key - Yahoo Finance
Is Vertex Pharmaceuticals Incorporated (VX1) stock overpriced at current multiplesJuly 2025 Update & Free Long-Term Investment Growth Plans - newser.com
Vertex Pharmaceuticals Incorporated $VRTX Shares Sold by Greenwood Capital Associates LLC - MarketBeat
Why Vertex Pharmaceuticals Incorporated (VX1) stock signals breakout potentialTrade Exit Summary & Low Risk Profit Maximizing Plans - newser.com
Mirae Asset Global Investments Co. Ltd. Acquires 1,270 Shares of Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Pure Financial Advisors LLC Raises Stock Position in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
What MACD signals say about Vertex Pharmaceuticals IncorporatedJuly 2025 Pullbacks & Low Volatility Stock Suggestions - newser.com
Published on: 2025-10-03 02:22:36 - newser.com
Published on: 2025-10-03 01:57:58 - newser.com
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
1.39%
4.36%
大文字化:
|
ボリューム (24 時間):